These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36122801)

  • 1. Prefrontal cortical response to natural rewards and self-reported anhedonia are associated with greater craving among recently withdrawn patients in residential treatment for opioid use disorder.
    Petrie DJ; Knapp KS; Freet CS; Deneke E; Brick TR; Cleveland HH; Bunce SC
    Brain Res Bull; 2022 Nov; 190():32-41. PubMed ID: 36122801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence.
    Huhn AS; Meyer RE; Harris JD; Ayaz H; Deneke E; Stankoski DM; Bunce SC
    Brain Res Bull; 2016 May; 123():102-9. PubMed ID: 26711857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association of prefrontal cortex response during a natural reward cue-reactivity paradigm, anhedonia, and demoralization in persons maintained on methadone.
    Huhn AS; Brooner RK; Sweeney MM; Antoine D; Hammond AS; Ayaz H; Dunn KE
    Addict Behav; 2021 Feb; 113():106673. PubMed ID: 33022538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.
    Huhn AS; Sweeney MM; Brooner RK; Kidorf MS; Tompkins DA; Ayaz H; Dunn KE
    Neuropsychopharmacology; 2019 Mar; 44(4):826-833. PubMed ID: 30375498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorder.
    Freet CS; Evans B; Brick TR; Deneke E; Wasserman EJ; Ballard SM; Stankoski DM; Kong L; Raja-Khan N; Nyland JE; Arnold AC; Krishnamurthy VB; Fernandez-Mendoza J; Cleveland HH; Scioli AD; Molchanow A; Messner AE; Ayaz H; Grigson PS; Bunce SC
    Addict Sci Clin Pract; 2024 Jul; 19(1):56. PubMed ID: 39061093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using ecological momentary assessments of negative affect and craving during residential opioid use disorder treatment to predict patients' relapse to substance use.
    Cleveland HH; Knapp KS; Cleveland MJ; Deneke E; Bunce SC
    J Subst Use Addict Treat; 2023 Mar; 146():208931. PubMed ID: 36880896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurobiological substrates of cue-elicited craving and anhedonia in recently abstinent opioid-dependent males.
    Zijlstra F; Veltman DJ; Booij J; van den Brink W; Franken IH
    Drug Alcohol Depend; 2009 Jan; 99(1-3):183-92. PubMed ID: 18823721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mindfulness-Oriented Recovery Enhancement reduces opioid craving among individuals with opioid use disorder and chronic pain in medication assisted treatment: Ecological momentary assessments from a stage 1 randomized controlled trial.
    Garland EL; Hanley AW; Kline A; Cooperman NA
    Drug Alcohol Depend; 2019 Oct; 203():61-65. PubMed ID: 31404850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible evidence for re-regulation of HPA axis and brain reward systems over time in treatment in prescription opioid-dependent patients.
    Bunce SC; Harris JD; Bixler EO; Taylor M; Muelly E; Deneke E; Thompson KW; Meyer RE
    J Addict Med; 2015; 9(1):53-60. PubMed ID: 25469651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I feel good? Anhedonia might not mean "without pleasure" for people treated for opioid use disorder.
    Stull SW; Bertz JW; Panlilio LV; Kowalczyk WJ; Phillips KA; Moran LM; Lin JL; Vahabzadeh M; Finan PH; Preston KL; Epstein DH
    J Abnorm Psychol; 2021 Jul; 130(5):537-549. PubMed ID: 34472889
    [No Abstract]   [Full Text] [Related]  

  • 11. Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.
    Cook JW; Lanza ST; Chu W; Baker TB; Piper ME
    Nicotine Tob Res; 2017 Jun; 19(6):703-709. PubMed ID: 28486709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anhedonia in chronic pain and prescription opioid misuse.
    Garland EL; Trøstheim M; Eikemo M; Ernst G; Leknes S
    Psychol Med; 2020 Sep; 50(12):1977-1988. PubMed ID: 31422776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder.
    Shi Z; Jagannathan K; Padley JH; Wang AL; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    Addict Biol; 2021 Jul; 26(4):e12977. PubMed ID: 33098179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of anhedonia with the Snaith-Hamilton Pleasure Scale (SHAPS) in adult outpatients with major depressive disorder.
    Nakonezny PA; Morris DW; Greer TL; Byerly MJ; Carmody TJ; Grannemann BD; Bernstein IH; Trivedi MH
    J Psychiatr Res; 2015 Jun; 65():124-30. PubMed ID: 25864641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulated opioid choice linked to opioid use disorder severity among veterans with chronic pain: initial validation of a novel paradigm.
    Parikh A; Moeller SJ; Garland EL
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):403-412. PubMed ID: 35100056
    [No Abstract]   [Full Text] [Related]  

  • 16. Daily meaningfulness among patients with opioid use disorder: Examining the role of social experiences during residential treatment and links with post-treatment relapse.
    Knapp KS; Brick TR; Bunce SC; Deneke E; Cleveland HH
    Addict Behav; 2021 Aug; 119():106914. PubMed ID: 33857730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily associations among craving, affect, and social interactions in the lives of patients during residential opioid use disorder treatment.
    Knapp KS; Bunce SC; Brick TR; Deneke E; Cleveland HH
    Psychol Addict Behav; 2021 Aug; 35(5):609-620. PubMed ID: 33090811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social anhedonia and medial prefrontal response to mutual liking in late adolescents.
    Healey KL; Morgan J; Musselman SC; Olino TM; Forbes EE
    Brain Cogn; 2014 Aug; 89():39-50. PubMed ID: 24412087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive affective functioning in anhedonic individuals' daily life: Anything but flat and blunted.
    Heininga VE; van Roekel E; Ahles JJ; Oldehinkel AJ; Mezulis AH
    J Affect Disord; 2017 Aug; 218():437-445. PubMed ID: 28531841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.